home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  April 13, 2021
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [4] [7] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 502 active entries

Fibroin Biologics (LARO)

An SBO Co. in Information Services
C. -B.

Phone: 16049458408
Fax: 16039419022


Fibroin Biologics, our Latin American-wide research organization (LARO) utilizes sourcing of information on sugarcane, agave and seagrass varieties as fibroin feedstock resources for manufacturing scaled up fermentation for SCP, producing peptones enriched media, and glucose syrup, from genetically bred and enzymatically treated ligno-cellulose from plant cropping, via enzymic hydrolysis, and glucose in complete media (with NPN) and via solid-substrate fermentation for inoculum, both for making 'clean meat' protein products from mammalian cell fermentation such as: duck cell-based meat, chicken cell-based meat, egg white from poultry, deli - like meatballs, hot dogs and sausages and dairy products like milk used to make cheeses and creamed dairy (e. g. whipped confectioners yogurt and cream cheese confectionaries for cakes, cookies and pastries).

It is predicted that these will be available in the marketplace by this year 2021 - following scale-up success expected through advances in industrial biotechnology.  

Other products we are following are fibro-derived bioethanol and biokerosene also new developments arising in Latin America. These are featured in our entry on this web portal at: Bio-kerosene, Port Coquitlam, British Columbia CA V3B 1G3. 

Selected Categories:
Product Company   Service Company
- Services
- Communications

Last update of this entry: January 06, 2021

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.